Detalhe da pesquisa
1.
Alcohol Craving and Severity are Associated with Dorsal Anterior Cingulate Choline Levels in Individuals with an Alcohol Use Disorder.
Alcohol Alcohol
; 58(3): 289-297, 2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939375
2.
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study.
Am J Drug Alcohol Abuse
; 49(3): 333-344, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282988
3.
Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.
Alcohol Alcohol
; 57(6): 727-733, 2022 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788255
4.
Immune treatments for alcohol use disorder: A translational framework.
Brain Behav Immun
; 97: 349-364, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343618
5.
Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder.
Alcohol Clin Exp Res
; 45(10): 2017-2028, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585396
6.
Clinical and Neural Correlates of Reward and Relief Drinking.
Alcohol Clin Exp Res
; 45(1): 194-203, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119924
7.
Endotoxin for Alcohol Research: A Call for Experimental Medicine Using Lipopolysaccharide Challenge.
Alcohol Alcohol
; 56(6): 715-717, 2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33592623
8.
The gut microbiome in alcohol use disorder and alcohol-associated liver disease: A systematic review of clinical studies.
Alcohol Clin Exp Res (Hoboken)
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719790
9.
Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge.
Alcohol Clin Exp Res (Hoboken)
; 47(10): 1859-1868, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864529
10.
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology.
Alcohol Clin Exp Res (Hoboken)
; 47(9): 1629-1645, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423771
11.
Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers.
Psychopharmacology (Berl)
; 239(5): 1387-1395, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34652499
12.
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
Drugs
; 82(3): 251-274, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133639
13.
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
Drug Alcohol Depend
; 225: 108825, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175784
14.
Diminished cortical response to risk and loss during risky decision making in alcohol use disorder.
Drug Alcohol Depend
; 218: 108391, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33153830
15.
Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial.
Trials
; 21(1): 779, 2020 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32912290
16.
Association between impulsivity and neural activation to alcohol cues in heavy drinkers.
Psychiatry Res Neuroimaging
; 293: 110986, 2019 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31622796